JUL 20, 2021 8:00 AM PDT

Bacterial Mitigation Strategies, the FDA Guidance and Implications for Blood Centers and Transfusion Services

Sponsored by: BD
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Date:  July 20, 2021
Time: 8:00am (PDT),  11:00am (EDT)
 
The FDA released their guidance, Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion, in September 2019, since updated in December 2020, with an implementation date of October 2021. Due to their room temperature storage requirements which foster bacterial growth, platelets are more likely than any other blood product, to result in a septic transfusion reaction, leading to considerable patient morbidity and mortality. These storage requirements also limit shelf life to 5-days, contributing to a labile platelet inventory. The guidance is intended to enhance both safety and availability of platelet products. Numerous strategies, including traditional culture-based methods, rapid tests and pathogen reduction technology, have been approved to reduce the risk of septic transfusion reactions. Each strategy has implications for every step in the life of a unit of platelets, from collection to manufacturing and distribution to transfusion. Safety features, feasibility, cost, and impact to platelet availability are factors that influence strategy selection for both blood collectors and transfusion services.
 
Learning Objectives
  • Interpret the purpose of the FDA guidance
  • Describe the one-step and two-step strategies approved for bacterial mitigation
  • Explain the implication of each strategy for blood suppliers and transfusion services
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAR 29, 2022 8:00 AM PDT
C.E. CREDITS
MAR 29, 2022 8:00 AM PDT
Date: March 29, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CET) Every purchasing decision you make for your lab today impacts the environmental stor...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
Loading Comments...
Show Resources